Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 53 of AN2 Therapeutics, Inc.'s SEC filings and found 2 warrant series, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for ANTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ADAGAdagene Inc. American Depositary Shares
YARWYarrow Bioscience Inc
ALXOALX Oncology Holdings Inc.
PEPGPepGen Inc.
PDSBPDS Biotechnology Corporation
CNTNCanton Strategic Holdings Inc
STROSutro Biopharma, Inc.
ORMPOramed Pharmaceuticals Inc.
IPHAInnate Pharma S.A. ADS
IVVDInvivyd, Inc.
WHWKWhitehawk Therapeutics Inc
MDWDMediWound Ltd.
ZNTLZentalis Pharmaceuticals, Inc.
ACOGAlpha Cognition Inc
MGNXMacroGenics, Inc.